img

Global Small Molecule Protein Degradation Agent Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Small Molecule Protein Degradation Agent Market Research Report 2024

According to QYResearch’s new survey, global Small Molecule Protein Degradation Agent market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Small Molecule Protein Degradation Agent market research.
Key manufacturers engaged in the Small Molecule Protein Degradation Agent industry include BMS, Monte Rosa Therapeutics, Nurix, Novartis, Eisai, Boehringer Ingelheim, Proxygen, Merck Sharp & Dohme and Arvinas, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Small Molecule Protein Degradation Agent were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Small Molecule Protein Degradation Agent market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Small Molecule Protein Degradation Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


BMS
Monte Rosa Therapeutics
Nurix
Novartis
Eisai
Boehringer Ingelheim
Proxygen
Merck Sharp & Dohme
Arvinas
Amgen
Shanghai Meizhi Pharmaceutical
Fendi Technology
Five-Membered Creatures
Gluetacs Therapeutics
Hengrui Medicine
Degron Therapeutics
Segment by Type
Molecular Gel Degrader
Protein Degradation Targets Chimeras

Segment by Application


Oncology Treatment
Cancer Treatment
Treatment Of Neurodegenerative Diseases
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Small Molecule Protein Degradation Agent report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Small Molecule Protein Degradation Agent Market Overview
1.1 Product Overview and Scope of Small Molecule Protein Degradation Agent
1.2 Small Molecule Protein Degradation Agent Segment by Type
1.2.1 Global Small Molecule Protein Degradation Agent Market Value Comparison by Type (2024-2034)
1.2.2 Molecular Gel Degrader
1.2.3 Protein Degradation Targets Chimeras
1.3 Small Molecule Protein Degradation Agent Segment by Application
1.3.1 Global Small Molecule Protein Degradation Agent Market Value by Application: (2024-2034)
1.3.2 Oncology Treatment
1.3.3 Cancer Treatment
1.3.4 Treatment Of Neurodegenerative Diseases
1.3.5 Other
1.4 Global Small Molecule Protein Degradation Agent Market Size Estimates and Forecasts
1.4.1 Global Small Molecule Protein Degradation Agent Revenue 2018-2034
1.4.2 Global Small Molecule Protein Degradation Agent Sales 2018-2034
1.4.3 Global Small Molecule Protein Degradation Agent Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Small Molecule Protein Degradation Agent Market Competition by Manufacturers
2.1 Global Small Molecule Protein Degradation Agent Sales Market Share by Manufacturers (2018-2024)
2.2 Global Small Molecule Protein Degradation Agent Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Small Molecule Protein Degradation Agent Average Price by Manufacturers (2018-2024)
2.4 Global Small Molecule Protein Degradation Agent Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Small Molecule Protein Degradation Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Small Molecule Protein Degradation Agent, Product Type & Application
2.7 Small Molecule Protein Degradation Agent Market Competitive Situation and Trends
2.7.1 Small Molecule Protein Degradation Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Small Molecule Protein Degradation Agent Players Market Share by Revenue
2.7.3 Global Small Molecule Protein Degradation Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Small Molecule Protein Degradation Agent Retrospective Market Scenario by Region
3.1 Global Small Molecule Protein Degradation Agent Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Small Molecule Protein Degradation Agent Global Small Molecule Protein Degradation Agent Sales by Region: 2018-2034
3.2.1 Global Small Molecule Protein Degradation Agent Sales by Region: 2018-2024
3.2.2 Global Small Molecule Protein Degradation Agent Sales by Region: 2024-2034
3.3 Global Small Molecule Protein Degradation Agent Global Small Molecule Protein Degradation Agent Revenue by Region: 2018-2034
3.3.1 Global Small Molecule Protein Degradation Agent Revenue by Region: 2018-2024
3.3.2 Global Small Molecule Protein Degradation Agent Revenue by Region: 2024-2034
3.4 North America Small Molecule Protein Degradation Agent Market Facts & Figures by Country
3.4.1 North America Small Molecule Protein Degradation Agent Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Small Molecule Protein Degradation Agent Sales by Country (2018-2034)
3.4.3 North America Small Molecule Protein Degradation Agent Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Small Molecule Protein Degradation Agent Market Facts & Figures by Country
3.5.1 Europe Small Molecule Protein Degradation Agent Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Small Molecule Protein Degradation Agent Sales by Country (2018-2034)
3.5.3 Europe Small Molecule Protein Degradation Agent Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Small Molecule Protein Degradation Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Small Molecule Protein Degradation Agent Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Small Molecule Protein Degradation Agent Sales by Country (2018-2034)
3.6.3 Asia Pacific Small Molecule Protein Degradation Agent Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Small Molecule Protein Degradation Agent Market Facts & Figures by Country
3.7.1 Latin America Small Molecule Protein Degradation Agent Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Small Molecule Protein Degradation Agent Sales by Country (2018-2034)
3.7.3 Latin America Small Molecule Protein Degradation Agent Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Small Molecule Protein Degradation Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Small Molecule Protein Degradation Agent Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Small Molecule Protein Degradation Agent Sales by Country (2018-2034)
3.8.3 Middle East and Africa Small Molecule Protein Degradation Agent Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Small Molecule Protein Degradation Agent Sales by Type (2018-2034)
4.1.1 Global Small Molecule Protein Degradation Agent Sales by Type (2018-2024)
4.1.2 Global Small Molecule Protein Degradation Agent Sales by Type (2024-2034)
4.1.3 Global Small Molecule Protein Degradation Agent Sales Market Share by Type (2018-2034)
4.2 Global Small Molecule Protein Degradation Agent Revenue by Type (2018-2034)
4.2.1 Global Small Molecule Protein Degradation Agent Revenue by Type (2018-2024)
4.2.2 Global Small Molecule Protein Degradation Agent Revenue by Type (2024-2034)
4.2.3 Global Small Molecule Protein Degradation Agent Revenue Market Share by Type (2018-2034)
4.3 Global Small Molecule Protein Degradation Agent Price by Type (2018-2034)
5 Segment by Application
5.1 Global Small Molecule Protein Degradation Agent Sales by Application (2018-2034)
5.1.1 Global Small Molecule Protein Degradation Agent Sales by Application (2018-2024)
5.1.2 Global Small Molecule Protein Degradation Agent Sales by Application (2024-2034)
5.1.3 Global Small Molecule Protein Degradation Agent Sales Market Share by Application (2018-2034)
5.2 Global Small Molecule Protein Degradation Agent Revenue by Application (2018-2034)
5.2.1 Global Small Molecule Protein Degradation Agent Revenue by Application (2018-2024)
5.2.2 Global Small Molecule Protein Degradation Agent Revenue by Application (2024-2034)
5.2.3 Global Small Molecule Protein Degradation Agent Revenue Market Share by Application (2018-2034)
5.3 Global Small Molecule Protein Degradation Agent Price by Application (2018-2034)
6 Key Companies Profiled
6.1 BMS
6.1.1 BMS Corporation Information
6.1.2 BMS Description and Business Overview
6.1.3 BMS Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.1.4 BMS Small Molecule Protein Degradation Agent Product Portfolio
6.1.5 BMS Recent Developments/Updates
6.2 Monte Rosa Therapeutics
6.2.1 Monte Rosa Therapeutics Corporation Information
6.2.2 Monte Rosa Therapeutics Description and Business Overview
6.2.3 Monte Rosa Therapeutics Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Monte Rosa Therapeutics Small Molecule Protein Degradation Agent Product Portfolio
6.2.5 Monte Rosa Therapeutics Recent Developments/Updates
6.3 Nurix
6.3.1 Nurix Corporation Information
6.3.2 Nurix Description and Business Overview
6.3.3 Nurix Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Nurix Small Molecule Protein Degradation Agent Product Portfolio
6.3.5 Nurix Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Novartis Small Molecule Protein Degradation Agent Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Eisai
6.5.1 Eisai Corporation Information
6.5.2 Eisai Description and Business Overview
6.5.3 Eisai Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Eisai Small Molecule Protein Degradation Agent Product Portfolio
6.5.5 Eisai Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Boehringer Ingelheim Small Molecule Protein Degradation Agent Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Proxygen
6.6.1 Proxygen Corporation Information
6.6.2 Proxygen Description and Business Overview
6.6.3 Proxygen Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Proxygen Small Molecule Protein Degradation Agent Product Portfolio
6.7.5 Proxygen Recent Developments/Updates
6.8 Merck Sharp & Dohme
6.8.1 Merck Sharp & Dohme Corporation Information
6.8.2 Merck Sharp & Dohme Description and Business Overview
6.8.3 Merck Sharp & Dohme Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Merck Sharp & Dohme Small Molecule Protein Degradation Agent Product Portfolio
6.8.5 Merck Sharp & Dohme Recent Developments/Updates
6.9 Arvinas
6.9.1 Arvinas Corporation Information
6.9.2 Arvinas Description and Business Overview
6.9.3 Arvinas Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Arvinas Small Molecule Protein Degradation Agent Product Portfolio
6.9.5 Arvinas Recent Developments/Updates
6.10 Amgen
6.10.1 Amgen Corporation Information
6.10.2 Amgen Description and Business Overview
6.10.3 Amgen Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Amgen Small Molecule Protein Degradation Agent Product Portfolio
6.10.5 Amgen Recent Developments/Updates
6.11 Shanghai Meizhi Pharmaceutical
6.11.1 Shanghai Meizhi Pharmaceutical Corporation Information
6.11.2 Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Description and Business Overview
6.11.3 Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Product Portfolio
6.11.5 Shanghai Meizhi Pharmaceutical Recent Developments/Updates
6.12 Fendi Technology
6.12.1 Fendi Technology Corporation Information
6.12.2 Fendi Technology Small Molecule Protein Degradation Agent Description and Business Overview
6.12.3 Fendi Technology Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Fendi Technology Small Molecule Protein Degradation Agent Product Portfolio
6.12.5 Fendi Technology Recent Developments/Updates
6.13 Five-Membered Creatures
6.13.1 Five-Membered Creatures Corporation Information
6.13.2 Five-Membered Creatures Small Molecule Protein Degradation Agent Description and Business Overview
6.13.3 Five-Membered Creatures Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Five-Membered Creatures Small Molecule Protein Degradation Agent Product Portfolio
6.13.5 Five-Membered Creatures Recent Developments/Updates
6.14 Gluetacs Therapeutics
6.14.1 Gluetacs Therapeutics Corporation Information
6.14.2 Gluetacs Therapeutics Small Molecule Protein Degradation Agent Description and Business Overview
6.14.3 Gluetacs Therapeutics Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Gluetacs Therapeutics Small Molecule Protein Degradation Agent Product Portfolio
6.14.5 Gluetacs Therapeutics Recent Developments/Updates
6.15 Hengrui Medicine
6.15.1 Hengrui Medicine Corporation Information
6.15.2 Hengrui Medicine Small Molecule Protein Degradation Agent Description and Business Overview
6.15.3 Hengrui Medicine Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Hengrui Medicine Small Molecule Protein Degradation Agent Product Portfolio
6.15.5 Hengrui Medicine Recent Developments/Updates
6.16 Degron Therapeutics
6.16.1 Degron Therapeutics Corporation Information
6.16.2 Degron Therapeutics Small Molecule Protein Degradation Agent Description and Business Overview
6.16.3 Degron Therapeutics Small Molecule Protein Degradation Agent Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Degron Therapeutics Small Molecule Protein Degradation Agent Product Portfolio
6.16.5 Degron Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Small Molecule Protein Degradation Agent Industry Chain Analysis
7.2 Small Molecule Protein Degradation Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Small Molecule Protein Degradation Agent Production Mode & Process
7.4 Small Molecule Protein Degradation Agent Sales and Marketing
7.4.1 Small Molecule Protein Degradation Agent Sales Channels
7.4.2 Small Molecule Protein Degradation Agent Distributors
7.5 Small Molecule Protein Degradation Agent Customers
8 Small Molecule Protein Degradation Agent Market Dynamics
8.1 Small Molecule Protein Degradation Agent Industry Trends
8.2 Small Molecule Protein Degradation Agent Market Drivers
8.3 Small Molecule Protein Degradation Agent Market Challenges
8.4 Small Molecule Protein Degradation Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Small Molecule Protein Degradation Agent Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Small Molecule Protein Degradation Agent Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Small Molecule Protein Degradation Agent Market Competitive Situation by Manufacturers in 2022
Table 4. Global Small Molecule Protein Degradation Agent Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Small Molecule Protein Degradation Agent Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Small Molecule Protein Degradation Agent Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Small Molecule Protein Degradation Agent Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Small Molecule Protein Degradation Agent Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Small Molecule Protein Degradation Agent, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Small Molecule Protein Degradation Agent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Small Molecule Protein Degradation Agent, Product Type & Application
Table 12. Global Key Manufacturers of Small Molecule Protein Degradation Agent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Small Molecule Protein Degradation Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Protein Degradation Agent as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Small Molecule Protein Degradation Agent Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Small Molecule Protein Degradation Agent Sales by Region (2018-2024) & (K Units)
Table 18. Global Small Molecule Protein Degradation Agent Sales Market Share by Region (2018-2024)
Table 19. Global Small Molecule Protein Degradation Agent Sales by Region (2024-2034) & (K Units)
Table 20. Global Small Molecule Protein Degradation Agent Sales Market Share by Region (2024-2034)
Table 21. Global Small Molecule Protein Degradation Agent Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Small Molecule Protein Degradation Agent Revenue Market Share by Region (2018-2024)
Table 23. Global Small Molecule Protein Degradation Agent Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Small Molecule Protein Degradation Agent Revenue Market Share by Region (2024-2034)
Table 25. North America Small Molecule Protein Degradation Agent Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Small Molecule Protein Degradation Agent Sales by Country (2018-2024) & (K Units)
Table 27. North America Small Molecule Protein Degradation Agent Sales by Country (2024-2034) & (K Units)
Table 28. North America Small Molecule Protein Degradation Agent Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Small Molecule Protein Degradation Agent Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Small Molecule Protein Degradation Agent Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Small Molecule Protein Degradation Agent Sales by Country (2018-2024) & (K Units)
Table 32. Europe Small Molecule Protein Degradation Agent Sales by Country (2024-2034) & (K Units)
Table 33. Europe Small Molecule Protein Degradation Agent Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Small Molecule Protein Degradation Agent Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Small Molecule Protein Degradation Agent Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Small Molecule Protein Degradation Agent Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Small Molecule Protein Degradation Agent Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Small Molecule Protein Degradation Agent Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Small Molecule Protein Degradation Agent Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Small Molecule Protein Degradation Agent Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Small Molecule Protein Degradation Agent Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Small Molecule Protein Degradation Agent Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Small Molecule Protein Degradation Agent Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Small Molecule Protein Degradation Agent Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Small Molecule Protein Degradation Agent Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Small Molecule Protein Degradation Agent Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Small Molecule Protein Degradation Agent Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Small Molecule Protein Degradation Agent Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Small Molecule Protein Degradation Agent Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Small Molecule Protein Degradation Agent Sales (K Units) by Type (2018-2024)
Table 51. Global Small Molecule Protein Degradation Agent Sales (K Units) by Type (2024-2034)
Table 52. Global Small Molecule Protein Degradation Agent Sales Market Share by Type (2018-2024)
Table 53. Global Small Molecule Protein Degradation Agent Sales Market Share by Type (2024-2034)
Table 54. Global Small Molecule Protein Degradation Agent Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Small Molecule Protein Degradation Agent Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Small Molecule Protein Degradation Agent Revenue Market Share by Type (2018-2024)
Table 57. Global Small Molecule Protein Degradation Agent Revenue Market Share by Type (2024-2034)
Table 58. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Type (2018-2024)
Table 59. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Type (2024-2034)
Table 60. Global Small Molecule Protein Degradation Agent Sales (K Units) by Application (2018-2024)
Table 61. Global Small Molecule Protein Degradation Agent Sales (K Units) by Application (2024-2034)
Table 62. Global Small Molecule Protein Degradation Agent Sales Market Share by Application (2018-2024)
Table 63. Global Small Molecule Protein Degradation Agent Sales Market Share by Application (2024-2034)
Table 64. Global Small Molecule Protein Degradation Agent Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Small Molecule Protein Degradation Agent Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Small Molecule Protein Degradation Agent Revenue Market Share by Application (2018-2024)
Table 67. Global Small Molecule Protein Degradation Agent Revenue Market Share by Application (2024-2034)
Table 68. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Application (2018-2024)
Table 69. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Application (2024-2034)
Table 70. BMS Corporation Information
Table 71. BMS Description and Business Overview
Table 72. BMS Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. BMS Small Molecule Protein Degradation Agent Product
Table 74. BMS Recent Developments/Updates
Table 75. Monte Rosa Therapeutics Corporation Information
Table 76. Monte Rosa Therapeutics Description and Business Overview
Table 77. Monte Rosa Therapeutics Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Monte Rosa Therapeutics Small Molecule Protein Degradation Agent Product
Table 79. Monte Rosa Therapeutics Recent Developments/Updates
Table 80. Nurix Corporation Information
Table 81. Nurix Description and Business Overview
Table 82. Nurix Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Nurix Small Molecule Protein Degradation Agent Product
Table 84. Nurix Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Novartis Small Molecule Protein Degradation Agent Product
Table 89. Novartis Recent Developments/Updates
Table 90. Eisai Corporation Information
Table 91. Eisai Description and Business Overview
Table 92. Eisai Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Eisai Small Molecule Protein Degradation Agent Product
Table 94. Eisai Recent Developments/Updates
Table 95. Boehringer Ingelheim Corporation Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Boehringer Ingelheim Small Molecule Protein Degradation Agent Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Proxygen Corporation Information
Table 101. Proxygen Description and Business Overview
Table 102. Proxygen Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Proxygen Small Molecule Protein Degradation Agent Product
Table 104. Proxygen Recent Developments/Updates
Table 105. Merck Sharp & Dohme Corporation Information
Table 106. Merck Sharp & Dohme Description and Business Overview
Table 107. Merck Sharp & Dohme Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Merck Sharp & Dohme Small Molecule Protein Degradation Agent Product
Table 109. Merck Sharp & Dohme Recent Developments/Updates
Table 110. Arvinas Corporation Information
Table 111. Arvinas Description and Business Overview
Table 112. Arvinas Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Arvinas Small Molecule Protein Degradation Agent Product
Table 114. Arvinas Recent Developments/Updates
Table 115. Amgen Corporation Information
Table 116. Amgen Description and Business Overview
Table 117. Amgen Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Amgen Small Molecule Protein Degradation Agent Product
Table 119. Amgen Recent Developments/Updates
Table 120. Shanghai Meizhi Pharmaceutical Corporation Information
Table 121. Shanghai Meizhi Pharmaceutical Description and Business Overview
Table 122. Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Shanghai Meizhi Pharmaceutical Small Molecule Protein Degradation Agent Product
Table 124. Shanghai Meizhi Pharmaceutical Recent Developments/Updates
Table 125. Fendi Technology Corporation Information
Table 126. Fendi Technology Description and Business Overview
Table 127. Fendi Technology Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Fendi Technology Small Molecule Protein Degradation Agent Product
Table 129. Fendi Technology Recent Developments/Updates
Table 130. Five-Membered Creatures Corporation Information
Table 131. Five-Membered Creatures Description and Business Overview
Table 132. Five-Membered Creatures Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Five-Membered Creatures Small Molecule Protein Degradation Agent Product
Table 134. Five-Membered Creatures Recent Developments/Updates
Table 135. Gluetacs Therapeutics Corporation Information
Table 136. Gluetacs Therapeutics Description and Business Overview
Table 137. Gluetacs Therapeutics Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Gluetacs Therapeutics Small Molecule Protein Degradation Agent Product
Table 139. Gluetacs Therapeutics Recent Developments/Updates
Table 140. Hengrui Medicine Corporation Information
Table 141. Hengrui Medicine Description and Business Overview
Table 142. Hengrui Medicine Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Hengrui Medicine Small Molecule Protein Degradation Agent Product
Table 144. Hengrui Medicine Recent Developments/Updates
Table 145. Degron Therapeutics Corporation Information
Table 146. Degron Therapeutics Description and Business Overview
Table 147. Degron Therapeutics Small Molecule Protein Degradation Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Degron Therapeutics Small Molecule Protein Degradation Agent Product
Table 149. Degron Therapeutics Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Small Molecule Protein Degradation Agent Distributors List
Table 153. Small Molecule Protein Degradation Agent Customers List
Table 154. Small Molecule Protein Degradation Agent Market Trends
Table 155. Small Molecule Protein Degradation Agent Market Drivers
Table 156. Small Molecule Protein Degradation Agent Market Challenges
Table 157. Small Molecule Protein Degradation Agent Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Small Molecule Protein Degradation Agent
Figure 2. Global Small Molecule Protein Degradation Agent Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Small Molecule Protein Degradation Agent Market Share by Type in 2022 & 2034
Figure 4. Molecular Gel Degrader Product Picture
Figure 5. Protein Degradation Targets Chimeras Product Picture
Figure 6. Global Small Molecule Protein Degradation Agent Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Small Molecule Protein Degradation Agent Market Share by Application in 2022 & 2034
Figure 8. Oncology Treatment
Figure 9. Cancer Treatment
Figure 10. Treatment Of Neurodegenerative Diseases
Figure 11. Other
Figure 12. Global Small Molecule Protein Degradation Agent Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Small Molecule Protein Degradation Agent Market Size (2018-2034) & (US$ Million)
Figure 14. Global Small Molecule Protein Degradation Agent Sales (2018-2034) & (K Units)
Figure 15. Global Small Molecule Protein Degradation Agent Average Price (US$/Unit) & (2018-2034)
Figure 16. Small Molecule Protein Degradation Agent Report Years Considered
Figure 17. Small Molecule Protein Degradation Agent Sales Share by Manufacturers in 2022
Figure 18. Global Small Molecule Protein Degradation Agent Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Small Molecule Protein Degradation Agent Players: Market Share by Revenue in 2022
Figure 20. Small Molecule Protein Degradation Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Small Molecule Protein Degradation Agent Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 22. North America Small Molecule Protein Degradation Agent Sales Market Share by Country (2018-2034)
Figure 23. North America Small Molecule Protein Degradation Agent Revenue Market Share by Country (2018-2034)
Figure 24. United States Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Small Molecule Protein Degradation Agent Sales Market Share by Country (2018-2034)
Figure 27. Europe Small Molecule Protein Degradation Agent Revenue Market Share by Country (2018-2034)
Figure 28. Germany Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Small Molecule Protein Degradation Agent Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Small Molecule Protein Degradation Agent Revenue Market Share by Region (2018-2034)
Figure 35. China Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. China Taiwan Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Southeast Asia Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Latin America Small Molecule Protein Degradation Agent Sales Market Share by Country (2018-2034)
Figure 43. Latin America Small Molecule Protein Degradation Agent Revenue Market Share by Country (2018-2034)
Figure 44. Mexico Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Brazil Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Argentina Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Small Molecule Protein Degradation Agent Sales Market Share by Country (2018-2034)
Figure 48. Middle East & Africa Small Molecule Protein Degradation Agent Revenue Market Share by Country (2018-2034)
Figure 49. Turkey Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. UAE Small Molecule Protein Degradation Agent Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Small Molecule Protein Degradation Agent by Type (2018-2034)
Figure 53. Global Revenue Market Share of Small Molecule Protein Degradation Agent by Type (2018-2034)
Figure 54. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Type (2018-2034)
Figure 55. Global Sales Market Share of Small Molecule Protein Degradation Agent by Application (2018-2034)
Figure 56. Global Revenue Market Share of Small Molecule Protein Degradation Agent by Application (2018-2034)
Figure 57. Global Small Molecule Protein Degradation Agent Price (US$/Unit) by Application (2018-2034)
Figure 58. Small Molecule Protein Degradation Agent Value Chain
Figure 59. Small Molecule Protein Degradation Agent Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed